[123I]5-IA-85380 SPECT Imaging of beta2-Nicotinic Acetylcholine Receptor Availability in the Aging Human Brain
- 1 February 2007
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1097 (1) , 168-170
Abstract
Human postmortem studies have reported decreases with age in high-affinity nicotine binding in brain. We have been investigating in vivo the availability of the beta(2)-containing nicotinic acetylcholine receptor (beta(2)-nAChR) in healthy nonsmokers (18-85 years of age) using [(123)I]5-IA-85380 SPECT imaging. Age and regional beta(2)-nAChR availability (V(T)(,)) have been observed to be inversely correlated in all brain regions analyzed, with decline ranging from 21% (cerebellum) to 36% (thalamus), or by up to 5% per decade of life. Preliminary results have confirmed postmortem reports of age-related decline in high-affinity nicotine binding with age and may elucidate the role of beta(2)-nAChRs in the cognitive decline associated with aging.Keywords
This publication has 4 references indexed in Scilit:
- Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123I]5-I-A-85380 in healthy human subjectsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Measurement of plasma metabolites of (S)-5-[123I]iodo-3- (2-azetidinylmethoxy)pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in nonhuman primatesNuclear Medicine and Biology, 2001
- Human nicotinic receptors—Their role in aging and dementiaNeurochemistry International, 1994
- “Mini-mental state”Journal of Psychiatric Research, 1975